MedPath

Megestrol Acetate

Megestrol Acetate Tablet USP

Approved
Approval ID

4f94daf8-ceb9-4577-ab71-8b7e3db7ff8e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

May 3, 2022

Manufacturers
FDA

Par Pharmaceutical, Inc.

DUNS: 092733690

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Megestrol Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49884-290
Application NumberANDA072423
Product Classification
M
Marketing Category
C73584
G
Generic Name
Megestrol Acetate
Product Specifications
Route of AdministrationORAL
Effective DateMay 3, 2022
FDA Product Classification

INGREDIENTS (1)

MEGESTROL ACETATEActive
Quantity: 40 mg in 1 1
Code: TJ2M0FR8ES
Classification: ACTIB

Megestrol Acetate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code49884-289
Application NumberANDA072422
Product Classification
M
Marketing Category
C73584
G
Generic Name
Megestrol Acetate
Product Specifications
Route of AdministrationORAL
Effective DateMay 3, 2022
FDA Product Classification

INGREDIENTS (1)

MEGESTROL ACETATEActive
Quantity: 20 mg in 1 1
Code: TJ2M0FR8ES
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Megestrol Acetate - FDA Drug Approval Details